SCHEMBL6593046

SCHEMBL6593046

CCC1C=CC=CC1(O)NCCCc1ccc2oc(-c3oc(=O)c(C)c(O)c3C)cc2c1

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 1/20 0.33
ALOX5 P09917 2/20 0.32
PTGES O14684 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6596752 0.95 FFAR1 (0.31) S1PR1
SCHEMBL6590502 0.85 MAOB (0.34) S1PR1
SCHEMBL6593044 0.72 AKR1B10 (0.37) ALOX5PTGES
SCHEMBL6593040 0.72 SIGMAR1 (0.42) S1PR1ALOX5PTGES
SCHEMBL27559006 0.70 FFAR1 (0.41) S1PR1ALOX5PTGES
SCHEMBL28747065 0.69 FFAR1 (0.40) S1PR1ALOX5PTGES
SCHEMBL6596747 0.69 FFAR1 (0.38) ALOX5PTGES
SCHEMBL6592910 0.68 ADRB1 (0.44)
SCHEMBL6594796 0.68 FFAR1 (0.35) S1PR1ALOX5PTGES
SCHEMBL6592355 0.68 NPC1 (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1063235-B1 BENZOFURYLPYRONE DERIVATIVES TEIJIN LTD (JP) 2004-05-12 EP disclosed
US-20030186976-A1 Benzofurylpyrone derivatives TEIJIN LIMITED, MICROBIAL CHEMISTRY RESEARCH FOUNDATION 2003-10-02 US disclosed
US-6589984-B1 Blood cholesterol and triglycerides (TG) themselves are generally insoluble in blood, and they exist as lipoproteins by binding with apolipoproteins. In the body, triglycerides are biosynthesized primarily in the liver from acetyl CoA as TEIJIN LIMITED (JP) 2003-07-08 US disclosed
EP-1063235-A1 BENZOFURYLPYRONE DERIVATIVES TEIJIN LIMITED (JP) 2000-12-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030186976-A1 Benzofurylpyrone derivatives PLIN5, ACSL5, PLIN1 S1PR1 1927/4885ALOX5 45/4885PTGES 1168/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.